Article Sidebar
Published:
Jun 26, 2026DOI:
10.4314/ahs.v26i2.13Keywords:
Article Details
While African Health Sciences has been freely accessible online there have been questions on whether it is Open Access or not. We wish to clearly state that indeed African Health Sciences is Open Access. There are key issues regarding Open Access needing clarification for avoidance of doubt:
- 1. Henceforth, papers in African Health Sciences will be published under the CC BY (Creative Commons Attribution License) 4.0 International. See details on https://creativecomons.org/)
- 2. The copyright owners or the authors grant the 3rd party (perpetually and in advance) the right to disseminate, reproduce, or use the research papers in part or in full, format/medium as long as:
- No substantive errors are introduced in the process
- Attribution of authorship and correct citation details are given
- The referencing details are not changed.
Should the papers be reproduced in part, this must be clearly stated.
- 3. The papers will be freely and universally accessible online in an easily readable format such as XML in at least one widely recognized open access repository such as PUBMED CENTRAL.
B. ABRIDGED LICENCE AGREEMENT BETWEEN AUTHORS AND African Health Sciences
I submitted my manuscript to African Health Sciences and would like to affirm that:
1.0 I am authorized by my co-authors to enter into these arrangements.
2.0 I guarantee, on behalf of self and co-authors:
- That the paper is original, and has not been published in any other peer-reviewed journal; nor is it under consideration by other journal (s). It does not infringe existing copyright or any other person’s rights
- That we are/I am the sole author(s) of the paper and with authority to enter into this agreement. My granting rights to African Health Sciences is not in breach of any other obligation
- That the paper contains nothing unlawful, or libelous. Nor anything that would constitute a breach of contract, confidence or commitment given to secrecy, if published
- That I/we have taken care to ensure the integrity of the article.
3.0 I and all co-authors, agree that the paper, if accepted for publication, shall be licensed under the Creative Commons Attribution License 4.0. (see https://creativecommons.org/)
Main Article Content
Treatment methods and recurrence rates in primary spontaneous pneumothorax: a 10-year retrospective study
Abstract
Aim: Primary spontaneous pneumothorax (PSP) predominantly affects young individuals and presents with variable treatment outcomes and considerable recurrence rates. Understanding the relationship between treatment approach and recurrence is essential for guiding clinical decision-making. The aim of this study was to evaluate demographic characteristics, treatment modalities, and recurrence rates in patients with PSP.
Methods: This single-center, retrospective study included patients diagnosed with PSP between January 2014 and December 2023. Recurrence rates following treatment were analyzed.
Results: A total of 314 patients (median age 28 years; 93.0% male) were included. Tube thoracostomy was the initial treatment in 250 patients (79.6%). Recurrence occurred in 78 patients (24.8%), with higher rates following tube thoracostomy (28.0%) compared to oxygen therapy (17.8%). No recurrence was observed after initial video-assisted thoracoscopic surgery (VATS). In recurrent cases, 44.9% underwent VATS, 25.6% tube thoracostomy, and 29.5% oxygen therapy. Treatment choice and smoking status showed significant associations (p<0.001 for the first episode and p=0.007 for the second episode). Notably, all patients who underwent VATS were smokers.
Conclusions: VATS performed during the first pneumothorax episode in selected patients prevents recurrence. The feasibility of VATS as the first treatment option in selected patients should be further investigated in larger series.
Keywords: Pleural Diseases; Primary Spontaneous Pneumothorax; Recurrence; Risk Factors; Smoking; Thoracoscopic Surgery Video-Assisted; Treatment Outcome.
